EXPLORING THE POTENTIAL BUDGET IMPACT OF EMICIZUMAB FOR HEMOPHILIA A WITH INHIBITOR IN ITALY

被引：0
|
作者：
Cortesi, P. A. [1 ]
D'Angiolella, L. S. [1 ]
Ferrario, M. [2 ]
Cesana, G. [1 ]
Mantovani, L. G. [1 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] Roche SpA, Monza, Italy
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2619
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY42
引用
收藏
页码：S442 / S443
页数：3
相关论文
共 50 条
  • [41] Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis
    Naruto Shimonishi
    Kana Sasai
    Kenichi Ogiwara
    Shoko Furukawa
    Yuto Nakajima
    Kuniyoshi Mizumachi
    Koji Yada
    Masahiro Takeyama
    Midori Shima
    Narumi Mizuno
    Keiji Nogami
    [J]. International Journal of Hematology, 2023, 118 : 690 - 698
  • [42] Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case report
    Fuko Kawahara
    Rie Shirayama
    Takuma Ito
    Koichi Oshida
    Tetsuji Sato
    Koichi Kusuhara
    [J]. International Journal of Hematology, 2022, 115 : 906 - 912
  • [43] Emicizumab in tolerized patients with hemophilia A with inhibitors: A single-institution pediatric cohort assessing inhibitor status
    Batsuli, Glaivy
    Greene, Amanda
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (02) : 342 - 348
  • [44] Assessment of the impact of pharmaceutical consultations at initiation of a treatment with emicizumab in patients with severe hemophilia A without inhibitors
    Allah, M. Nasr
    Pieragostini, R.
    Oka, G.
    Batista, R.
    Stieltjes, N.
    Lopez, I.
    [J]. ANNALES PHARMACEUTIQUES FRANCAISES, 2022, 80 (06): : 915 - 922
  • [45] IMPACT OF SWITCHING PROPHYLAXIS TREATMENT FROM FACTOR VIII TO EMICIZUMAB IN HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
    Escobar, Miguel
    Agrawal, Neha
    Chatterjee, Sagnik
    Bhattacharya, Swastik
    Caicedo, Jorge
    Bullano, Michael
    Schultz, Robert G.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E34 - E34
  • [46] THE ECONOMIC IMPACT OF REDUCING BLEEDING WITH EMICIZUMAB IN PATIENTS WITH HEMOPHILIA A AND FACTOR VIII INHIBITORS - BRAZILIAN CASE
    Segre, N.
    Mata, V
    Martins, T. D. C.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S165 - S165
  • [47] Impact of switching prophylaxis treatment from factor VIII to emicizumab in hemophilia A patients without inhibitors
    Escobar, Miguel
    Agrawal, Neha
    Chatterjee, Sagnik
    Bhattacharya, Swastik
    Caicedo, Jorge
    Bullano, Michael
    Schultz, Bob G. G.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 574 - 580
  • [48] Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy
    Hatayama, Yuki
    Motokura, Toru
    Hosoda, Yuzuru
    Suzuki, Sayaka
    Namba, Hiroya
    Kato, Konami
    Kojima, Nao
    Horie, Takuya
    Iwamoto, Takuya
    Yamashita, Noriko
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [49] Perioperative Monitoring with Global Coagulation Test in Severe Hemophilia a without Inhibitor on Emicizumab Prophylaxis Undergoing Orthopedic Surgery
    Dos Santos Ortas, Abel
    Martin De Bustamante Gonzalez-Iglesias, Jose Manuel
    Perez Vaquero, Maria Isabel
    Alvarez Roman, Maria Teresa
    Rivas Pollmar, Maria Isabel
    Martin Salces, Monica
    Garcia Perez, Eduardo
    Gutierrez, Mar
    Arias-Salgado, Elena G.
    Butta, Nora, V
    Acuna, Paula
    Monzon Manzano, Elena
    Hermans, Cedric
    Jimenez-Yuste, Victor
    [J]. BLOOD, 2022, 140 : 11302 - 11303
  • [50] Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy
    Hatayama, Yuki
    Motokura, Toru
    Hosoda, Yuzuru
    Suzuki, Sayaka
    Namba, Hiroya
    Kato, Konami
    Kojima, Nao
    Horie, Takuya
    Iwamoto, Takuya
    Yamashita, Noriko
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
12345